Association between serum lithium level and incidence of COVID-19 infection, BJPsych

Health records analysis (n=26,554) found 6-month COVID-19 infection incidence lower in matched patients with ' therapeutic ' vs. ' subtherapeutic ' lithium levels [LLs] (HR 0.82; 95% CI 0.69 –0.97,p=0.017)& among those with ' therapeutic ' LLs vs. on valproate (0.79;0.67 –0.92,p=0.0023)

Source: Current Awareness Service for Health (CASH) - March 25, 2022 Category: Consumer Health News Source Type: news